Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that six clinical abstracts demonstrating the broad use of its NeXT Personal® test will be ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostic Services Program ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc., a leader in advanced genomics for precision oncology (Nasdaq: PSNL), disclosed a reduction in headcount impacting approximately 20% of the company’s ...
Dr. Chen expands his leadership role to serve as President while continuing to serve as Chief Medical Officer (CMO), unifying R&D innovation with operational execution as Personalis defines the next ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Personalis, Inc., a provider of advanced genomic sequencing and analytics for cancer and immuno-oncology, today announced that the company has been awarded a new ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the launch of its proprietary Neoantigen Presentation Score (NEOPS).
Cathie Wood’s Bold Investment; Personalis (NASDAQ:PSNL) reported first-quarter 2026 revenue of $15.5 million as management said the company is p ...
Throughout the last three months, 5 analysts have evaluated Personalis (NASDAQ:PSNL), offering a diverse set of opinions from bullish to bearish. The table below summarizes their recent ratings, ...
Investors weren't very happy when shares tanked in March, but have been smiling ever since. Personalis is an underdog in cancer genomics, according to Mr. Market, who has assigned the stock the ...
The analyst fair value estimate for Personalis has been nudged to US$11.29 from US$11.00, a small adjustment that still matters if you are tracking valuation closely. This shift aligns with recent, ...
Personalis Inc. PSNL received a favorable reimbursement decision that could make its cancer test available to more patients — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results